Nuclear Factor- (cid:1) B–Mediated Cell Survival Involves Transcriptional Silencing of the Mitochondrial Death Gene BNIP3 in Ventricular Myocytes
Nuclear Factor- (cid:1) B–Mediated Cell Survival Involves Transcriptional Silencing of the Mitochondrial Death Gene BNIP3 in Ventricular Myocytes
复制标题
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Background —A survival role for the transcription factor nuclear factor- (cid:1) B (NF- (cid:1) B) in ventricular myocytes has been reported; however, the underlying mechanism is undefined. In this report we provide new mechanistic evidence that survival signals conferred by NF- (cid:1) B impinge on the hypoxia-inducible death factor BNIP3. Methods and Results —Activation of the NF- (cid:1) B signaling pathway by IKK (cid:2) in ventricular myocytes suppressed mitochondrial permeability transition pore (PTP) opening and cell death provoked by BNIP3. Expression of IKK (cid:2) or p65 NF- (cid:1) B suppressed basal and hypoxia-inducible BNIP3 gene activity. Deletion analysis of the BNIP3 promoter revealed the NF- (cid:1) B elements to be crucial for inhibiting basal and inducible BNIP3 gene activity. Cells derived from p65 (cid:1) / (cid:1) -deficient mice or ventricular myocytes rendered defective for NF- (cid:1) B signaling with a nonphosphorylative I (cid:1) B exhibited increased basal BNIP3 gene expression, mitochondrial PTP, and cell death. Genetic or functional ablation of the BNIP3 gene in NF- (cid:1) B–defective myocytes rescued them from mitochondrial defects and cell death. Conclusions —The data provide new compelling evidence that NF- (cid:1) B suppresses mitochondrial defects and cell death of ventricular myocytes through a mechanism that transcriptionally silences the death gene BNIP3. Collectively, our data provide new mechanistic insight into the mode by which NF- (cid:1) B suppresses cell death and identify BNIP3 as a key transcriptional target for NF- (cid:1) B–regulated expression in ventricular myocytes. ( Circulation . 2005;112:3777-3785.) Our earlier work identified BNIP3 to be a central factor in the cell death process during hypoxic injury. We demonstrate that under normal oxygen tension, BNIP3 poses no threat to the viability of the cell because it is “switched off” by the cellular factor nuclear factor- (cid:1) B (NF- (cid:1) B). The biological actions of NF- (cid:1) B work in a way analogous to the brakes of a car, which prevent the car from moving. We show that during hypoxia NF- (cid:1) B is inactivated, releasing the “brakes” and “switching on” BNIP3. This results in elevated BNIP3 levels and cell death of heart cells. Furthermore, we show that genetic interventions that “mimic” the braking actions of NF- (cid:1) B suppress BNIP3 gene activation and cell death of ventricular myocytes during hypoxia. The clinical importance of this study holds promise for the design of new therapies that specifically target components of the cell death pathway as a means to prevent inordinate cell loss and improve ventricular function in patients after infarction.